Preprint uses LLM on health records to track rising BPC-157 use
Authors say patients typically wait about two months before telling clinicians they are using the unapproved repair peptide, if they disclose at all.
PR
By Priya Raman · Science Reporter
Oct 7 13:00 ETSource: The Verge
The wire
- 01A retrospective preprint applied a large language model to anonymized electronic health records to detect BPC-157 mentions in clinical notes, reporting sharp growth in use over the last three years.
- 02BPC-157 has no insurance code and no uniform way for providers to document it, so clinicians taking histories may miss it entirely unless they ask directly about injections and research chemicals.
- 03The preprint is not peer reviewed and the detection method is imperfect; a 2025 systematic review found only 35 preclinical studies and a single human clinical study of BPC-157.
From the source
Read at theverge.comThe scariest thing about gray-market peptides is how little we know
Researchers found that BPC-157 users tend to wait two months before disclosing usage to doctors — if they disclose at all.
